MACQUARIE GROUP LTD - DICERNA PHARMACEUTICALS INC ownership

DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 178 filers reported holding DICERNA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.

Quarter-by-quarter ownership
MACQUARIE GROUP LTD ownership history of DICERNA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$32,000
-45.8%
1,5850.0%0.00%
Q2 2021$59,000
+22.9%
1,585
-15.2%
0.00%
Q1 2021$48,000
-11.1%
1,870
-23.5%
0.00%
Q4 2020$54,000
+22.7%
2,4430.0%0.00%
Q3 2020$44,000
-29.0%
2,4430.0%0.00%
Q2 2020$62,000
+3000.0%
2,443
+1121.5%
0.00%
Q4 2018$2,000
-66.7%
200
-50.0%
0.00%
Q3 2018$6,0004000.00%
Other shareholders
DICERNA PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 1,813,392$67,676,00017.58%
Bain Capital Life Sciences Investors, LLC 3,080,237$114,954,0007.53%
RTW INVESTMENTS, LP 7,521,859$280,716,0004.24%
DAFNA Capital Management LLC 510,756$19,061,0003.99%
SILVERARC CAPITAL MANAGEMENT, LLC 229,892$8,580,0003.83%
Parkman Healthcare Partners LLC 304,686$11,371,0002.49%
Evolutionary Tree Capital Management, LLC 141,324$5,274,0002.43%
Eagle Health Investments LP 161,125$6,013,0002.06%
Lombard Odier Asset Management (Switzerland) SA 636,011$23,736,0001.20%
Woodline Partners LP 1,000,325$37,332,0000.70%
View complete list of DICERNA PHARMACEUTICALS INC shareholders